lisdexamfetamine dimesylate 30 MG Chewable Tablet
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
lisdexamfetamine dimesylate 30 MG Chewable Tablet
30 MG · Chewable Tablet · oral
A form of lisdexamfetamine dimesylate →
lisdexamfetamine dimesylate 30 MG Chewable Tablet — Centrally acting sympathomimetics. Strength, form, class, interactions & more.
Active ingredient
Classification
Centrally acting sympathomimeticsCentral Nervous System Stimulant
Drug interactions
Lisdexamfetamine dimesylate has several clinically important drug interactions that can affect its metabolism and efficacy.
- majorMAO Inhibitors (MAOI) — Increased risk of hypertensive crisis and toxic neurological effects.
- majorserotonergic drugs — Increased risk of serotonin syndrome.
- majorCYP2D6 inhibitors — Increased exposure of dextroamphetamine and risk of serotonin syndrome.
- majoralkalinizing agents — Increased blood levels and potentiation of amphetamine action.
- majoracidifying agents — Decreased blood levels and efficacy of amphetamines.
- moderatetricyclic antidepressants — Enhanced activity of tricyclic agents and increased cardiovascular effects.
Real-world adverse events (FAERS)
Drug Ineffective4,564Fatigue1,991Off Label Use1,986Anxiety1,751Headache1,707Product Availability Issue1,564Nausea1,506Insomnia1,455
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication